Synlogic to Host Analyst & Investor Event at the Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting

On November 1, 2018 Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to probiotics to develop novel, living medicines, reported that the Company will host an event for analysts and investors in conjunction with the Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper)’s 33rd Annual Meeting * Pre-Conference Programs (SITC 2018), with formal presentations beginning at 12:30 pm ET on November 10, 2018 (Press release, Synlogic, NOV 1, 2018, View Source [SID1234530624]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

At SITC (Free SITC Whitepaper) 2018, Synlogic will deliver a poster presentation of preclinical data for its innate immune activator candidate. Details about the poster presentation and abstract are below:

Title: Development of a STING Agonist-producing Synthetic Biotic Medicine to Activate Innate and Adaptive Immunity and Drive Antitumor Immune Responses
Abstract ID: P624
Location: Poster Hall Location: Hall E
Time:Friday, Nov. 9 from 8:00 am– 8:00 pm ET and Saturday, Nov. 10 from 8:00 am – 8:30 pm ET
The analyst and investor event will expand on these data to highlight the potential of Synlogic’s Synthetic Biotic platform in immuno-oncology, with featured speakers including:

Synlogic management
Filip Janku, MD, PhD; MD Anderson Cancer Center
Dmitriy Zamarin, MD, PhD; Memorial Sloan Kettering Cancer Center
A live webcast of the presentation and accompanying slides will be available under "Events and Presentations" in the News & Investors section of the Company’s website at www.synlogictx.com. An archived webcast recording of the event will be available on the website for approximately 30 days.